KJELLIN , Midori; WESSLÉN , Terése; LÖFBLAD , Erik; LENNERSTRAND , Johan; LANNERGÅRD , Anders. The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort. Upsala Journal of Medical Sciences, [S. l.], v. 123, n. 1, p. 50–56, 2018. DOI: 10.1080/03009734.2018.1441928. Disponível em: https://ujms.net/index.php/ujms/article/view/5824. Acesso em: 16 nov. 2026.